Grant: Doctoral Research Award: Canada Graduate Scholarships
Queen's University (Kingston, Ontario)
$120,000.00
Platelet Bioenergetics: Identifying a 'Liquid Biopsy' for Skeletal Muscle Mitochondrial Health in Cardiometabolic Disease
FY 2024-25
Summary
Cardiometabolic diseases (CMDs) are related conditions including obesity, high cholesterol, blood sugar, and blood pressure. CMDs significantly increase the risk of heart disease and type 2 diabetes, affecting >20% of Canadians. Central to CMD is the body's ability to process glucose, an essential energy source. Skeletal muscle plays a major role in glucose control, but when it becomes resistant to insulin (a hormone that regulates sugar levels) during CMD, the risk of heart disease and diabetes increase. Mitochondria, the energy-producing powerhouses in cells, are central to this dysfunction. However, assessing mitochondrial function in muscle is challenging due to the need for invasive biopsies.
This research offers a non-invasive alternative by using platelets, a type of blood cell, as a marker for mitochondrial health. Early findings suggest that bioenergetics of platelets mirror the metabolism of muscle cells, offering a potential "liquid biopsy" for monitoring CMD risk. We will also explore how mitochondrial DNA (mtDNA), which varies between populations due to ancient human migration patterns, impacts susceptibility to CMD. Notably, CMD rates differ significantly across ancestry groups, with some exhibiting higher rates of disease/mortality even when adjusting for age, sex, and socioeconomic status. Genome-wide studies do not fully explain these disparities. Studying mtDNA differences may offer insights into why some groups face higher risks, and understanding these genetic factors may improve early detection and management.
We will examine how mtDNA, diet, and sex influence mitochondrial function in muscle and platelets using genetically engineered mice and human participants. By tracking mitochondrial health over time, we hope to identify early changes that signal CMD onset. Identifying mtDNA-linked mitochondrial patterns will help tailor prevention strategies for high-risk individuals and improve personalized care while addressing healthcare inequalities.
Department
Program
Doctoral Research Award: Canada Graduate Scholarships
Location
Ontario, Canada
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
518459
Name
Wilkinson Mia S
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Platelet Bioenergetics: Identifying a 'Liquid Biopsy' for Skeletal Muscle Mitochondrial Health in Cardiometabolic Disease
Programtype2
Studentship Programs
Orgnameinp2
Queen's University (Kingston, Ontario)
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Bioenergetics; Biomarker; Blood Platelets; Cardiometabolic Disease; Insulin Resistance; Mitochondria; Skeletal Muscle
Abstract
Cardiometabolic diseases (CMDs) are related conditions including obesity, high cholesterol, blood sugar, and blood pressure. CMDs significantly increase the risk of heart disease and type 2 diabetes, affecting >20% of Canadians. Central to CMD is the body's ability to process glucose, an essential energy source. Skeletal muscle plays a major role in glucose control, but when it becomes resistant to insulin (a hormone that regulates sugar levels) during CMD, the risk of heart disease and diabetes increase. Mitochondria, the energy-producing powerhouses in cells, are central to this dysfunction. However, assessing mitochondrial function in muscle is challenging due to the need for invasive biopsies.
This research offers a non-invasive alternative by using platelets, a type of blood cell, as a marker for mitochondrial health. Early findings suggest that bioenergetics of platelets mirror the metabolism of muscle cells, offering a potential "liquid biopsy" for monitoring CMD risk. We will also explore how mitochondrial DNA (mtDNA), which varies between populations due to ancient human migration patterns, impacts susceptibility to CMD. Notably, CMD rates differ significantly across ancestry groups, with some exhibiting higher rates of disease/mortality even when adjusting for age, sex, and socioeconomic status. Genome-wide studies do not fully explain these disparities. Studying mtDNA differences may offer insights into why some groups face higher risks, and understanding these genetic factors may improve early detection and management.
We will examine how mtDNA, diet, and sex influence mitochondrial function in muscle and platelets using genetically engineered mice and human participants. By tracking mitochondrial health over time, we hope to identify early changes that signal CMD onset. Identifying mtDNA-linked mitochondrial patterns will help tailor prevention strategies for high-risk individuals and improve personalized care while addressing healthcare inequalities.
Competitiondate
202411
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Wilkinson, Mia S
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~